Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 12 studies | 22% ± 5% | |
oligodendrocyte | 8 studies | 28% ± 8% | |
microglial cell | 7 studies | 30% ± 10% | |
vein endothelial cell | 6 studies | 26% ± 11% | |
squamous epithelial cell | 4 studies | 58% ± 13% | |
glutamatergic neuron | 4 studies | 38% ± 16% | |
capillary endothelial cell | 4 studies | 20% ± 6% | |
epithelial cell | 3 studies | 23% ± 10% | |
retinal pigment epithelial cell | 3 studies | 21% ± 4% | |
GABAergic neuron | 3 studies | 36% ± 10% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 4 studies | 37% ± 8% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 98% | 3236.23 | 2579 / 2642 | 97% | 24.44 | 681 / 705 |
stomach | 98% | 2426.90 | 353 / 359 | 92% | 56.22 | 264 / 286 |
intestine | 94% | 1636.88 | 912 / 966 | 96% | 56.37 | 507 / 527 |
kidney | 100% | 6972.70 | 89 / 89 | 90% | 51.21 | 814 / 901 |
pancreas | 94% | 1495.93 | 309 / 328 | 94% | 42.93 | 168 / 178 |
esophagus | 100% | 5240.25 | 1438 / 1445 | 85% | 47.93 | 156 / 183 |
lung | 100% | 7033.84 | 578 / 578 | 71% | 20.11 | 815 / 1155 |
bladder | 95% | 1667.62 | 20 / 21 | 70% | 27.73 | 351 / 504 |
breast | 100% | 3700.14 | 459 / 459 | 61% | 10.92 | 685 / 1118 |
uterus | 94% | 1886.91 | 159 / 170 | 56% | 14.65 | 255 / 459 |
thymus | 98% | 2186.00 | 643 / 653 | 45% | 4.50 | 274 / 605 |
prostate | 90% | 1397.94 | 220 / 245 | 34% | 3.12 | 173 / 502 |
skin | 72% | 3507.97 | 1298 / 1809 | 29% | 3.73 | 135 / 472 |
spleen | 100% | 3016.35 | 241 / 241 | 0% | 0 | 0 / 0 |
adipose | 100% | 3695.77 | 1201 / 1204 | 0% | 0 | 0 / 0 |
heart | 93% | 1351.10 | 801 / 861 | 0% | 0 | 0 / 0 |
adrenal gland | 48% | 429.53 | 123 / 258 | 23% | 2.83 | 54 / 230 |
liver | 37% | 323.08 | 84 / 226 | 32% | 11.58 | 128 / 406 |
blood vessel | 67% | 1099.20 | 896 / 1335 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 67% | 13.15 | 30 / 45 |
ovary | 20% | 260.94 | 36 / 180 | 39% | 5.41 | 167 / 430 |
muscle | 43% | 414.33 | 343 / 803 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 41% | 3.70 | 12 / 29 |
eye | 0% | 0 | 0 / 0 | 5% | 0.96 | 4 / 80 |
peripheral blood | 4% | 35.25 | 38 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0048535 | Biological process | lymph node development |
GO_0043029 | Biological process | T cell homeostasis |
GO_0030148 | Biological process | sphingolipid biosynthetic process |
GO_0007605 | Biological process | sensory perception of sound |
GO_0003376 | Biological process | sphingosine-1-phosphate receptor signaling pathway |
GO_0072676 | Biological process | lymphocyte migration |
GO_0060348 | Biological process | bone development |
GO_0002920 | Biological process | regulation of humoral immune response |
GO_0001782 | Biological process | B cell homeostasis |
GO_2000404 | Biological process | regulation of T cell migration |
GO_0048073 | Biological process | regulation of eye pigmentation |
GO_0055085 | Biological process | transmembrane transport |
GO_0006869 | Biological process | lipid transport |
GO_0010008 | Cellular component | endosome membrane |
GO_0005886 | Cellular component | plasma membrane |
GO_0016020 | Cellular component | membrane |
GO_0046624 | Molecular function | sphingolipid transporter activity |
GO_0022857 | Molecular function | transmembrane transporter activity |
Gene name | SPNS2 |
Protein name | Sphingosine-1-phosphate transporter SPNS2 (Protein spinster homolog 2) SPNS lysolipid transporter 2, sphingosine-1-phosphate |
Synonyms | |
Description | FUNCTION: Lipid transporter that specifically mediates export of sphingosine-1-phosphate (sphing-4-enine 1-phosphate, S1P) and sphinganine-1-phosphate in the lymph, thereby playing a role in lymphocyte trafficking . S1P is a bioactive signaling molecule that regulates many physiological processes important for the development and for the immune system . Regulates levels of S1P and the S1P gradient that exists between the high circulating concentrations of S1P and low tissue levels that control lymphocyte trafficking . Required for the egress of T-cells from lymph nodes during an immune response by mediating S1P secretion, which generates a gradient that enables activated T-cells to access lymph (By similarity). Also required for the egress of immature B-cells from the bone marrow (By similarity). In contrast, not involved in S1P release from red blood cells (By similarity). Involved in auditory function . S1P release in the inner ear is required for maintenance of the endocochlear potential in the cochlea (By similarity). In addition to export, also able to mediate S1P import (By similarity). . |
Accessions | ENST00000329078.8 I3L4N9 Q8IVW8 ENST00000571386.1 |